Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colitis, Ulcerative × ABX464 × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colitis, Ulcerative 1

Interventions

Specimen Handling 2 Nivolumab 2 Infliximab 2 Educational Status 2 pembrolizumab 1 golimumab 1 cabozantinib 1 Standard of Care 1 Practice Guidelines as Topic 1 Platinum Compounds 1 NX-13 1 Methods 1 Ipilimumab 1 Interviews as Topic 1 Early Intervention, Educational 1 Colonoscopy 1 CTLA-4 Antigen 1 CT-P13 1 Biopsy 1 Atorvastatin 1 Adalimumab 1 ABX464 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03760003 2025-11-28

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Abivax S.A.

Phase 2 Completed

355 enrolled 39 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡